Heramed
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 17 Oct 2024
- Reported shorts
- 23.6K
- Shares on issue
- 633.250M
Heramed (HMD) financials
Results, ratios and statements
Latest result
Half year to 30 Jun 2026 (HY26), figures in AUD, the reporting currency · Company filing, 28 Aug 2026
- Revenue
- n/avs n/a
- NPAT
- −$1.6MF (source: Company filing (extracted))vs n/a
- Company filing (extracted), as at 12 Oct 2026
- EPS (basic)
- n/avs n/a
- Rev YoY
- −19.5%FY
- EPS YoY
- n/aFY
- Company filing (extracted)
Summary of Appendix 4D and Half Year Report, 28 Aug 2026
HeraMED's half-year revenue fell 72.5% to $38,325, while its net loss narrowed 29.2% to $1.60 million. No dividend was declared. The company raised $3.2 million and is advancing US commercialisation with Lee Health and Philips, with cash of $2.93 million at period end.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 31 Dec 2025 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026
- Gross margin
- n/a
- Operating margin
- n/a
- Net margin
- −1,408.3%
- FCF margin
- n/a
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- n/a
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Sources: Yahoo Finance and ASX (Markit), as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| Revenue | $293.4KM (source: ASX (Markit)) | $364.3KM (source: ASX (Markit)) | $606.2KM (source: ASX (Markit)) | $315.8KM (source: ASX (Markit)) |
| NPAT | −$4.1MM (source: ASX (Markit)) | −$5.5MM (source: ASX (Markit)) | −$6.8MM (source: ASX (Markit)) | −$7.0MM (source: ASX (Markit)) |
| Shares | 1.07B | 875.6M | 328.4M | 248.0M |
- ASX (Markit)
Financial reports
The company's own filings, newest first
- Appendix 4D and Half Year ReportHalf Year Results28 Aug 2026via asx_announcements
Figures above come from this filing
- Annual Report to shareholdersAnnual Report27 Feb 2026via asx_announcements
- Preliminary Final ReportAnnual Results27 Feb 2026via asx_announcements
- Appendix 4D and Half Year ReportHalf Year Results28 Aug 2025via asx_announcements
- Annual Report to shareholdersAnnual Report28 Feb 2025via asx_announcements
- Preliminary Final ReportAnnual Results28 Feb 2025via asx_announcements
- Appendix 4D and Half Year ReportHalf Year Results28 Aug 2024via asx_announcements
- Annual Report to shareholdersAnnual Report28 Mar 2024via asx_announcements
- Appendix 4E & Preliminary Final ReportAnnual Results29 Feb 2024via asx_announcements
- Appendix 4D and Half Year ReportHalf Year Results18 Aug 2023via asx_announcements
Showing 10 of 61 reports